21207 ⎘
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
#302Peptide conjugated particles
#303Inactivated mycobacteria for oral use in the prevention of tuberculosis
#304Acellular pro-tolerogenic compositions and process for making same
#305Agent for Treating Allergic or Hypersensitivity Condition
#306Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
#307Methods of treating psoriasis using candida antigen
#308COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#309VACCINATION WITH INTERLEUKIN-4 ANTAGONISTS
#310METHODS OF DEPOSITING PARTICLES OF A SUBSTANCE IN A TISSUE
#311MTB-C vaccine against asthma
#312BIOMARKER
#313Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
#314T cell epitopes from Cockroach and methods of making and using same
#315Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with type B peptide
#316Cytokines and neuroantigens for treatment of immune disorders
#317Tolerisation-Inducing Composition
#318Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
#319Anti-TLR4 antibodies and methods of use thereof
#320Compositions and methods for immune tolerance induction
#321Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
#322Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
#323Treatment of food intolerance and food allergy with IgM
#324PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
#325Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance
#326Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
#327T-CELL ANTIGEN PEPTIDE FROM ALLERGEN FOR STIMULATION OF IL-10 PRODUCTION
#328Hypoallergenic variants of mal d 1, the major allergen from malus domestica
#329Hypoallergenic chimeric proteins belonging to the lipid transfer family of for use in the treatment of allergies
#330Peanut formulations and uses thereof
#331Effect of an attenuated strain against allergic disease
#332Programming of cells for tolerogenic therapies
#333Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#334Peptide for protection of allergic respiratory disorders
#335Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#336Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#337Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
#338METHODS OF TREATING ALLERGIES WITH SUBSTANTIALLY PHENOL-FREE CARRIERS
#339COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS
#340INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS
#341COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES
#342ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY
#343ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES
#344ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#345INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES
#346INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS
#347DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS
#348TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#349THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#350Allergen
#351Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
#352COMPOSITIONS AND METHODS FOR TREATING AIRWAY INFLAMMATORY DISEASES
#353IMMUNOGLOBULIN-LIKE TRANSCRIPT (ILT) RECEPTORS AS CD8 ANTAGONISTS
#354DNA vaccines and methods for the prevention of transplantation rejection
#355TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#356CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#357Tolerogenic synthetic nanocarriers for allergy therapy
#358TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#359Tolerogenic synthetic nanocarriers
#360Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#361TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#362TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#363Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#364Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#365Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#366Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#367Anti-TLR4 antibodies and methods of use thereof
#368Cancer therapy
#369Programming of cells for tolerogenic therapies
#370SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL
#371CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS
#372Erythrocyte-binding therapeutics
#373Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
#374Depletion of cancer stem cells
#375Treatment of celiac disease with IgA
#376USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS
#377Treating allergy with detoxified heat-labile enterotoxin
#378T-cell antigen peptide from allergen for stimulation of IL-10 production
#379Method of inducing tolerance to an allergen
#380System for delivery into XCR1 positive cell and uses thereof
#381RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
#382Vaccine peptide combinations against cat allergy
#383Method of inducing immune tolerance to type I diabetes
#384Methods of modulating the negative chemotaxis of immune cells
#385Hypoallergenic chimeric proteins belonging to the lipid transfer family of for use in the treatment of allergies
#386DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
#387Induction of mucosal tolerance to antigens
#388Agent for treating allergic or hypersensitivity condition
#389Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity